MUC1 and breast carcinoma: The incubation of MCF-7 and MDA-MB-231 breast cancer cells with Pt12, cisplatin, Pt12 with anti-MUC1, and cisplatin with anti-MUC1 induced the visible phosphatidylserine exposure after 24 and 48 h of treatment (Fig. 8).